← SynDRA
TAFAMIDIS
SynDRA canonical compound SYN0030040 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx |
|---|
| Primary target(s) | TTR |
|---|
| Mechanism of action | Transthyretin amyloid inhibitor |
|---|
| Indication | familial amyloid polyneuropathy (FAP) |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
- TTR
- ABCG2
- SLC22A6
- SLC22A8
Mechanisms of action (all sources)
- Transthyretin stabilizer
- Transthyretin amyloid inhibitor
- TTR STABILISER
- Transthyretin stabiliser
- TTR BINDER
- TTR BINDING AGENT
Drug classes
- Anti-Inflammatory Agents
- Glucocorticoids
- Immunosuppressive Agents
ATC classes
- N07X · OTHER NERVOUS SYSTEM DRUGS
Cross-references
Synonyms
- Fx-1006A
- Fx-1006
- tafamidis meglumine
- vyndaqel
- FX1006A
- vynmac
- FX-1005
- FX-1006
- FX1006
- Vyndamax
- Tafamidis meglumine
- Fx 1006A
- Fx1006A
- UNII-ZU7CF08A1A
- ZU7CF08A1A
- CHEBI:79345
- Tafamidis meglumine [USAN:INN]
- SCHEMBL14783506
- CHEMBL2105675
- Tafamidis meglumine (JAN/USAN)
- SB16821
- D-Glucitol, 1-deoxy-1-(methylamino)-, 2-(3,5-dichlorophenyl)-6-benzoxazolecarboxylate
- FT-0700926
- D09674
- 2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid--1-deoxy-1-(methylamino)-D-glucitol (1/1)
- 1-deoxy-1-(methylazaniumyl)-D-glucitol 2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylate
- FX005
- Fx 1006
- 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid
- UNII-8FG9H9D31J
- CHEBI:78538
- 2-(3,5-Dichlorophenyl)-6-benzoxazole carboxylic acid
- 8FG9H9D31J
- 2-(3,5-Dichlorophenyl)-6-benzoxazolecarboxylic Acid
- C14H7Cl2NO3
- 2-(3,5-dichlorophenyl)benzoxazole-6-carboxylic acid
- Tafamidis [USAN:INN]
Look up TAFAMIDIS in the interactive SynDRA portal →